247 related articles for article (PubMed ID: 7525705)
1. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
2. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
3. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
[TBL] [Abstract][Full Text] [Related]
4. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
5. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.
Fling SP; Arp B; Pious D
Nature; 1994 Apr; 368(6471):554-8. PubMed ID: 8139690
[TBL] [Abstract][Full Text] [Related]
6. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
8. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
[TBL] [Abstract][Full Text] [Related]
9. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines.
Kovats S; Whiteley PE; Concannon P; Rudensky AY; Blum JS
Eur J Immunol; 1997 Apr; 27(4):1014-21. PubMed ID: 9130658
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
[TBL] [Abstract][Full Text] [Related]
11. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
12. Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes.
Albert LJ; Denzin LK; Ghumman B; Bangia N; Cresswell P; Watts TH
Cell Immunol; 1998 Jan; 183(1):42-51. PubMed ID: 9578718
[TBL] [Abstract][Full Text] [Related]
13. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
14. DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing.
Ceman S; Rudersdorf RA; Petersen JM; DeMars R
J Immunol; 1995 Mar; 154(6):2545-56. PubMed ID: 7876531
[TBL] [Abstract][Full Text] [Related]
15. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
[TBL] [Abstract][Full Text] [Related]
16. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
17. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
18. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
Albert LJ; Ghumman B; Watts TH
J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
[TBL] [Abstract][Full Text] [Related]
19. Inefficient peptide binding by cell-surface class II MHC molecules.
Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE
Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
